‘Made in India’ Covaxin gets emergency use approval for children aged 2-18 years
In a notable moment for India's vaccination program, Bharat Biotech's COVAXIN has received emergency use approval for being administered to ...
In a notable moment for India's vaccination program, Bharat Biotech's COVAXIN has received emergency use approval for being administered to ...
India is preparing to launch the largest segment of its nationwide inoculation drive against the coronavirus on May 1. This ...
The second phase of the coronavirus vaccination has begun in Indore. About 10 locations, including 3 government-run facilities will be ...
India's very own indigenously developed COVID-19 vaccine, Covaxin has completed another trial phase in Kanpur. The trial included administering the ...